Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest
NCT03640949Phase 3Completed
- Start
- Sep 2018
- Primary completion
- Jan 2021
- Modality
- Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of vasopressin, methylprednisolone sodium succinate in cardiac arrest (SCA). Started Sep 2018; status: completed.
02
Drugs
vasopressinmethylprednisolone sodium succinate
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT03640949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03640949.